US 11,839,687 B2
Solid composition
Kamalinder Singh, Preston (GB)
Assigned to University of Central Lancashire, Preston (GB)
Appl. No. 16/754,061
Filed by University of Central Lancashire, Preston (GB)
PCT Filed Oct. 5, 2018, PCT No. PCT/GB2018/052855
§ 371(c)(1), (2) Date Apr. 6, 2020,
PCT Pub. No. WO2019/069096, PCT Pub. Date Apr. 11, 2019.
Claims priority of application No. 1716419 (GB), filed on Oct. 6, 2017.
Prior Publication US 2020/0323778 A1, Oct. 15, 2020
Int. Cl. A61K 9/14 (2006.01); A23L 33/12 (2016.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); B01J 13/08 (2006.01)
CPC A61K 9/145 (2013.01) [A23L 33/12 (2016.08); A61K 9/0053 (2013.01); A61K 9/1617 (2013.01); A61K 9/1694 (2013.01); B01J 13/08 (2013.01); A23V 2002/00 (2013.01)] 44 Claims
 
1. An orally-administrable solid composition, comprising isolated oil-loaded microparticles having an average particle size between 70 and 300 μm, wherein each of the oil-loaded microparticles comprises an oil component, present at a concentration of at least 10 wt %, co-mixed with a lipid component, present at a concentration of at least 20 wt %, such that the oil component and the lipid component are present in a respective weight ratio of between 10:90 and 60:40;
wherein:
the oil component comprises one or more oils corresponding respectively with one or more organic oils selected from animal oils, vegetable oils, and/or essential oils; and
the lipid component comprises one or more lipids corresponding respectively with one or more fatty acid esters whose fatty acid chains are saturated or unsaturated and comprise between 14 and 28 carbons; and
the oil component is a liquid at standard ambient temperature and pressure (SATP), whereas the lipid component and the solid composition are each independently solid at SATP.